Most Recent Interviews
- Ron Basak SmithHow Hemp Packaging Is Saving Our Oceans – with Ron Basak-Smith of Sana Packaging
- Cameron KelucheThis Groundbreaking Biotech Technology Is Revolutionizing Cannabis And Beyond – with Cameron Keluche of KelSie Biotech and SUM Microdose
- Drake Sutton-ShearerPRØHBTD Is Taking Cannabis From Black Market To Mainstream – With CEO Drake Sutton-Shearer
- Matt CutoneDispensary Sales Are Booming Thanks To This New Tool – With Seed CEO Matt Cutone
Listen in as Julianna Carella and Lauren Fraser of Auntie Dolores discuss how to create edibles that people really want. Auntie Dolores creates THC-infused edibles that include cakes, brownie bites, and their famous pretzels. Learn more at AuntieDolores.com
Matthew: Hi, I’m Matthew Kind. Each week I’ll take you behind the scenes to interview the insiders that are shaping the rapidly evolving legal marijuana industry. Learn more at www.cannainsider.com. That’s www.cannainsider.com. What are the five disruptive trends that will shape the cannabis industry in the next five years? Find out with your free report at www.cannainsider.com/trends. That’s www.cannainsider.com/trends. Now here’s your program. As we often talk about on CannaInsider, cannabis consumers’ preferences are quickly moving from flower to concentrates and edibles. Today we’re going to talk with Julianna Carella and Lauren Fraser if Auntie Dolores. Auntie Dolores makes some of the most talked about and delectable infused edibles. Julianna and Lauren welcome to CannaInsider.
Julianna: Thank you.
Lauren: Thanks Matt.
Matthew: I want to dig into infused products and Auntie Dolores, but before we go down that road, can you tell us where you are in the world?
Julianna: We’re based in Oakland.
Matthew: And where did the name Auntie Dolores come from?
Julianna: Well we got our start in San Francisco about six years ago, and Auntie Dolores comes from—the name Dolores actually means pain in Spanish—so it’s a play on words Auntie pain.
Matthew: That’s a good one. Yeah Dolor, you’re right, I did not make the connection.
Julianna: And cannabis is the best Auntie pain remedy there is.
Matthew: Good point. How did each of you get started in this industry? I mean this is a pretty specific career path.
Julianna: Yeah it is. It sort of unfolded and become more of a career path. It started off as a little side project. I had been baking with edibles for many years and, you know, and dispensaries started popping up in San Francisco and looking for more edibles to put on the shelf, more interesting products. That’s when we started to bring my products into the dispensaries, and so the timing was really good. There seemed to be a bit of void as far as what was available. So it was nice to get involved at that time.
Matthew: Now Julianna for somebody that’s never tried an edible before, how do you describe the difference in experience versus smoking flower?
Julianna: Well the onset is going to be coming on later. So you can usually plan for at least a half hour up to, I mean we’ve talked to patients that have said it’s taken three for their edible to take effect. So there’s a wide range. Generally speaking it takes about an hour for most people for the effects to become evident. And the duration of the experience is going to last longer than smoking or vaporizing will last. And so if you’re somebody that wants to be medicated for, you know, a duration of 4 plus hours, and you know you may not be in a position to, you know, take a break from work to go smoke or vaporize, but if you need that continuous (3.23 unclear), it’s a nice way to discretely medicate. And so those are some of the reasons that we think edibles are, you know, popular and gaining popularity is just the discression factor and duration of the effects, and then being able to really kind of titrate your dosage if you’re consuming edibles that come from, you know, a reliable source and the bakery or kitchen that does a good job at, you know, really making a consistent product.
Matthew: Now Julianna let’s dig into Auntie Dolores products a little bit. Can you tell us what you offer?
Julianna: Sure. So right now we have a product line of ten different products, and pretty much all the products, we are just actually revamped a lot of our recipes to make them even healthier. Our brownies are going to be low glycemic and vegan. And then the rest of our product line is vegan, gluten free, sugar free, low glycemic, you know, incorporate super foods like coconut oil. We use coconut sugar for sweetening all of our products because it’s diabetic friendly. So we’re interested in just creating really delicious, tasty foods. A lot of our products are savory and appeal to folks that maybe don’t have a big sweet tooth, but they still like to medicate with edibles. And so between the ten products half of them are savory, half are sweet. Most of them are vegan or gluten free or sugar free, and they’re all really delicious.
Matthew: Now you touched on super foods a little bit there. Can you talk about that a little more because I don’t know if you’ve read that book, Super Foods by David Wolfe, but he goes into cacao, goji berries, coconut oil, aloe. And super food, the term gets thrown around, but can you tell us a little bit more about what that means exactly?
Julianna: Yeah, you know, it’s something that I hear a lot about, super foods that term, and it seems to run around. Actually there’s a pretty specific list of criteria that a super food has to match that list to actually be considered a true super food. Coconut oil is definitely on that list. Cacao nibs is another ingredient we incorporate in our (5.44 unclear) cookies which is, you know, between the cacao nibs and the coconut oil and then the cannabis, I mean, the three of those ingredients together are just… it’s just a really, really pretty dynamic outcome when you’ve got all that going on. I mean the health benefits of coconut oil actually near a lot of the health benefits of the cannabinoids. So that’s really interesting. And then because we do a food grade extract with coconut oil, we’re using the full plant and all of it. So the full plant extract is what’s going into our edibles and it’s made with the coconut oil. And so it’s just a really healthy approach to consuming cannabinoids orally.
Matthew: Those cacao nibs that you’re talking about they’re like little shards of really super bitter cacao beans. They take a little bit of getting used to, but I find they are really healthful and especially combining those with a little bit of goji berry, it’s like one of my favorite things. But circling back to coconut oil, I don’t know if you’ve heard of this morning regimen. I have coconut oil in my coffee with some organic, grass fed, unsalted butter. Have you ever heard of that?
Julianna: Yes I talked with someone last week who is putting coconut oil in their coffee and I’ve never tried it. But yeah that’s so interesting. I mean there’s so many things you can do with coconut oil. It’s a topical, you can use it in your hair, I mean, it’s just, you know, like anything else. If you can put it on your skin and you can eat it, chances are it’s going to be really good for you. Just another note on the cacao nibs because he brought up a really good point. They are a slightly bitter flavor and eating them alone is pretty intense. When you incorporate them with chocolate and these other ingredients it kind of takes the edge off it, but you still get the benefit of it and you get the crunch and (7.41 unclear). So that’s really nice.
Matthew: Now you mentioned that your products aren’t overly sweet, but there is some sweetness to them. How do you sweeten them if there’s no sugar? Is it like agave or stevia or how does that work?
Julianna: Yeah we use coconut sugar for pretty much 9 out of 10 products or at least, excuse me, all the products that are sweet except for the caramel corn are made with coconut sugar. And so coconut sugar is actually mineral rich and it’s low glycemic. So it’s not going to spike your blood sugar. It’s diabetic friendly, and it’s really nice. We just came out with a new product the glazed pecans. We use the coconut sugar for that glazed pecan recipe. It’s vegan. It’s made with the coconut oil and the coconut sugar, but it tastes just like any other caramelized pecan. It’s just healthier for you and it has cannabis oil in it. But the coconut sugar is just, it’s really great, really great.
Matthew: Now everybody keeps on telling me I must try the Auntie Dolores, can you guess what I’m going say, which product it is?
Matthew: Yes, what is in these pretzels? It’s like I can’t go a few days without saying, have you tried an Auntie Dolores pretzel. What is with these pretzels? They sound delicious.
Julianna: It’s so funny. Well so the story behind the pretzels is, I mean, we released them like five years ago, the first year that we were bringing them to the dispensaries that we worked with back then. We’re like, nobody’s going to want to try it because there was not one savory product in the market. And so it took a little while, but once it caught on it was like gang busters and it’s just literally our most popular product. Basically there’s 30 ingredients in these pretzels. It’s a pretzel that’s coated with a special sauce that’s just really complex and masks the flavor of the cannabis really well. And they also have coconut oil in them, and I think just because they’re savory and sugar free, each pretzel is roughly 3 to 4mg. They can really triturate your dosage. Somebody who’s got a low tolerance might eat three or four pretzels, and you know, we’ve talked to people that eat one and that’s plenty for them. And then we have other patients that are eating the whole bag of 32 pretzels. So, you know, just kind of highlights the spectrum of tolerance levels and how our products, we really try to develop products that anybody can enjoy if they consume responsibly and that they, you know, take note of what one dosage constitutes for each of our products. And so it actually says that on the product packaging what one dose constitutes, and in the case of the pretzels it’s about two to three pretzels for one dose.
Matthew: Now you talked briefly about, you know, blood sugar normalization with coconut sugar and then there’s coconut oil in the pretzels. Does that kind of help lessen the blood sugar spike? Is that one of the designs of the coconut oil or is it just a complementary flavor?
Julianna: I’m not sure we could make that claim with the coconut oil. The other health benefits are certainly there in product. But most important would probably be the fact that we’re extracting the cannabinoids directly into the coconut oil. And so it’s just, it’s sort of the medium for actually infusing the product. And then in some cases we also use CO2 oil because that’s really nice for helping to kind of mask the flavor of cannabis because we end up using, you know, less volume of the CO2 oil than you would of an infused coconut oil. And so there’s a combination in some of our products, and then some products we just use coconut oil. Like for instance our dog treats have coconut oil because of the health benefits are really good for dogs as well.
Matthew: Well that’s interesting. Can you tell us a little bit more about the dog treats?
Julianna: Sure. Yeah, we have a company that’s called Kindest Pet, and it’s a new product. It was recently we changed the name from Treatables, and so some people know us as Treatables, but we’ve changed the name and we’ve rebranded the product. But it’s been out for about six months now. It’s doing really really well. It’s basically a bag of 40 dog treats, and these dog treats have no THC in them. They are not designed to intoxicate your dog. They’re specifically designed to address your dog’s health issues. And so it could be anything from cancer to epilepsy to separation anxiety to I mean you name it, all the same things that human beings benefit from CBD. Dogs also benefit in all those same ways. And so the response has been pretty overwhelming and people are loving the treats. It takes, you know, for the dogs that have separation anxiety, it’s nice for the pet owner as well as the pet to kind of lessen their anxiety. You know, I’m really excited about it.
Matthew: That is really cool. I haven’t heard of anything like that. And you know I often hear about dog food just being filled with these terrible fillers and other crazy things. Can you tell us some of the other ingredients beside CBD and non psychoactive components?
Julianna: Yeah absolutely. Yeah, it’s really important to us that the food that we’re sort of infusing the cannabis in also has to be healthy especially, you know, if you’re giving it to your pets and you’re trying to give your pet a good diet. These treats are actually vegan. They’re gluten free. They’re made with a protein rich oat flour that’s gluten free. And then there’s peanut butter, pumpkin, coconut oil like I said, a little bit of cinnamon for flavor and then a little bit of coconut fat which is like basically a syrup that comes from the coconut. And that’s it. And by itself, even without the cannabis, they’re actually really healthy dog treats that the CBD just sort of bumps it up a notch. Also there’s hemp oil in them. That’s really good for dogs as well.
Matthew: So we talked a little bit about the pretzels. What are the other one or two products you sell that are just… would you say are the most popular?
Julianna: Well our caramel corn is really popular. It’s delicious. And let’s see, the third most popular product would probably be our toffee brownies.
Matthew: Hmm. That sounds good.
Julianna: Yeah. We also have chili lime peanuts and glazed pecans and cocoa sparkle cookies. We’ve got cheese crackers. So there’s a wide range of flavors in the product line.
Matthew: And where can we buy Auntie Dolores edibles right now? Is it still only in California or is it moving to other medical dispensaries in different states?
Julianna: Yeah we are throughout California, all the way from Humble down to San Diego. We’re in dispensaries, and you know you can check us out online at our website to find any information. But also we are licensing the brand out of state. You’ll find the product in Washington soon probably within the next six to twelve months. The adult use (15.39 unclear) shops over in Washington. And then probably soon after that you’ll find our products in Nevada and Colorado, and then we’ll be moving into East Coast states after that.
Matthew: Now switching gears to baking a little bit and some of the mechanics of that, do you prefer baking with THC oil or butter? What’s your preference there?
Julianna: Well we only use cannabis butter for one of our products, maybe two of our products at this time. The rest of our products are vegan so they’re made with the coconut oil. But we do also infuse the products with super (16.24 unclear) CO2 cannabis oil. So it’s a combination of those.
Matthew: Is there any specific challenges to baking with cannabis that someone listening might be surprised about because I’ve heard things about how it has to bind with fat and different things and there’s just probably some specific details. Can you enlighten us?
Julianna: Yeah sure. Well the cannabinoids are fat soluble so you have to find a way to, you know, infuse medium which in this case it could be coconut oil or butter. For people who are trying this at home there’s so many recipes online that you can follow and they’re perfectly good for home baking. But my suggestion is to, if you’re going to use butter or coconut oil, you know we generally use about four ounces of cannabis trim for one cup of oil. So it comes out pretty strong, but if you make it as strong as you can possibly make it, then you can always kind of taper down by adding uninfused butter or oil to that to make it weaker. But it’s suggested to get your product tested before you start working with it so that you know exactly how many milligrams are in, you know, one gram of your product so that you can do the math on calculating how many milligrams you want in your batch of brownies or your lasagna or whatever you’re putting it in and how many servings you get from that particular recipe. So those are all components for baking with cannabis at home. Those are things to think of.
Matthew: Now we all hear stories about people that try edibles for the first time and don’t understand the dosages, and they might have a very interesting afternoon if they’re not paying attention to how much they’re eating. Can you help us understand dosages and packaging so people don’t make any mistakes?
Julianna: Sure so what we’ve sort of kind of adopted what Colorado and Washington and some of these other states have determined that 10mg is one dose, and that’s about what we’ve… we used to consider 12 to 15mg to be one dose. We’re following what Colorado and some of these other states are doing because most likely that will be what happens in California. And it’s just a really good place to start because most people that are either new to cannabis or they’re new to edibles, there’s really no reason to go above 10mg.
In fact that might be more than enough. So we even suggest starting with 5 if you’re a newcomer because the effects of the edibles are so much more profound than smoking or vaporizing and because the onset is delayed. It’s sort of a perfect recipe for a surprising afternoon if you’re not quite ready for the ride. So it’s really really suggested and this is something that happens. Almost all the time we hear the story continuously from people in general that they take a sample of the edible, they wait an hour, nothing’s happened, instead of waiting another hour they decide I’m just going to go ahead and eat more and that’s usually when the roller coaster ride starts because they’ve consumed probably, who knows how much, how many milligrams and you know quite possibly more than what they need. So then it’s not as enjoyable of an experience and oftentimes that experience alone can turn people off forever to edibles. So it’s actually really unfortunate, and we don’t like when that happens. It’s really important to us to label the product. We’ve just redesigned our packaging to make it even clearer. I mean it’s just so so important for people to know what they’re consuming and how many milligrams that is and what kind of effect they can expect.
Matthew: Now how do you come up with different food items? Do you experiment with friends and family? Do you have parties with guests? I mean, I’m curious here how this works and how I can get invited.
Julianna: You’re invited, don’t worry. Yeah we, you know, that’s kind of how it started off, you know, five-six years ago when we were sort of developing our menu, but we only develop maybe two to three new products a year, and then we’ll kind of let go of some of the other ones that have been around and maybe not as good of sellers. We’re interesting in finding products that, you know, that no one else is doing. And so you’re not going to see us, you know, creating like a chocolate bar. There’s plenty of chocolate bars out there so you know, and there’s certain other products that we just won’t do because they’re already out there. But if you look at our product line, most of our products no one else is doing. And that’s partly because I think our recipes are pretty complex, and we do that for a reason because we don’t want people to copy them.
So we’re interested, you know, making products that are easy to penetrate. So like in the case of the pretzels and the caramel corn and all these loose products that come in a package and you can take one or you can take ten, that’s how all of our products are. So the latest product that we just developed would be the glazed pecans. And we just really wanted a holiday product. The glazed pecans are a great holiday product. You know, you can put them on your salad. You can throw them in trail mix. I mean there’s so many different things you can do with the glazed pecans. And that was just a great timing since it’s a holiday product. That’s kind of sort of how we just come up with ideas we think of something that would be interesting and in the market and something that we know that we could successfully infuse and make it a consistent delicious product.
Matthew: Well you’ve certainly cracked the code there on new products. Switching gears to testing, testing’s becoming a huge part of the cannabis business and the ability to test for a lot of different things is expanding. And it’s not just about keeping out the bad things like mold, but also dialing in the desirable components of the plant. Can you tell us a little bit about testing and how you think about it and apply it to Auntie Dolores products?
Julianna: Yeah, well for us, you know, we work with multiple growers and we’ve got, you know, a set amount of strains that we’re working with, and that’s you know anywhere from eight to ten different strains of cannabis. So you know you can’t look at a cannabis plant and know exactly what the cannabinoids profile is, and so I mean we make our extract and then we take it to the lab so that we can see what all the levels are like on the THC, CBD, CBN, CBG, THCV, all of those cannabinoids just to see where we land. And it’s really quite impossible to even start baking with a product until you look at the lab results, if you’re trying to, you know, produce a product that you can quantify, you know, the dosage of the product. So the testing is really important on the potency side of it all. So it’s really important because you know we need to make sure that there’s no contaminants and any other things that you wouldn’t want ending up in your edibles.
Matthew: Now switching gears to brand. I have a question for you Lauren. You know I hear about stories about Steve Jobs from Apple and he says, or he used to say, you know, we don’t do focus groups, we don’t do any of this market testing. We just make what we would like to see. Is that the secret behind Auntie Dolores’s unique brand because there’s other edibles out there, but there’s not other edibles where people are always talking to me about it, telling me about it. You’ve got all these people, these brand advocates out there talking about Auntie Dolores. Why is that? How did this happen?
Lauren: Yes that’s a great question. I mean we have a really really loyal customer base who keep coming back because they love the products, they love the taste, but they also trust the brand. I mean Julianna hit on a few points. Just the consistency, everybody talks about consistency and it’s very important not just because people want the same experience every time, but it’s because it builds trust for a brand, and we don’t take that trust lightly. We’re really committed to our customers in maintaining that trust ever day. So new products and creativity, that all comes down to.. and we do tap into our customers a lot to figure out what it is that they would want and look at the gaps on the shelves, the gaps in the market and try to fill those gaps with things that really cater to true patients with dietary restrictions. We have a wellness focus. The Every Day Edible is our tagline, and so it really comes down to not just being a medicine, not just being a food, but being the product that you can integrate into your everyday life and in a space and safe way that you trust and that you love.
Matthew: So what’s on the horizon for 2015 as we draw to a close in 2014?
Lauren: Well in 2014 we’ve really been setting the foundation for a national expansion, been kind of planting the seeds and nurturing them, and we have a brand expansion model that allows us to legally bring the products to new emerging markets in the medical and adult use space through partnerships with licensed producer/processors. So in 2015 you’re going to see Auntie Dolores products launching in some new West Coast markets outside of California. And we’re actively looking for professional partners to work with in other states.
Lauren: Yeah, yeah and also this year we’re introducing some new products, also have some exciting initiatives that are really focused on education and awareness so that we can elevate not only our brand but the industry at large. It’s something that I think the company has always been politically active and a part of the community really, you know, not one of these kind of big brands that’s a bit separate. You’re seeing a lot of shift in the market right now, and as this market shifts and becomes bigger and new players come in, having those roots in your home state and the political roots and being a part of the movement for a long time is something that you’ll always see in Auntie Dolores.
Matthew: And so just to reiterate, what states are you looking for partners in?
Lauren: We are actively looking for partners in Colorado and Arizona and Illinois, eventually Florida. So there’s… we’ve been talking to people really across the nation, and I think as these markets get closer to coming on board we just want to have… we want to know the right people. We want to know the people who are doing things with the right intentions and people that we can partner with that have an aligned vision. But in terms of, you know, the next two years we’re really focused on entering West Coast states and we will be expanding after that.
Matthew: Great. And Julianna as we close, how can listeners learn more about Auntie Dolores products?
Julianna: Well you can visit our website and I’m going to spell it out for you and then I’ll give you the special media information. So it’s www.auntiedolores.com, and www.facebook.com/auntiedoloresedibles and www.twitter.com/auntiedolores.
Matthew: Great. Well Julianna and Lauren, thanks so much for being on CannaInsider today. We really appreciate it. If you enjoyed the show today, please consider leaving us a review on iTunes. Every five star review helps us to bring the best guests to you. Learn more at www.cannainsider.com/itunes. What are the five disruptive trends that will shape the cannabis industry in the next five years? Find out with your free report at www.cannainsider.com/trends. That's www.cannainsider.com/trends. Have a suggestion for an awesome guest on www.cannainsider.com, email us email@example.com. We would love to hear from you.
Renowned cannabis investor and advisor Leslie Bocskor gives us his prescient insights into where the cannabis industry is heading in 2015 and the exciting technologies that are emerging. Leslie goes into detail as to why he believes Las Vegas will become the Silicon Valley of Cannabis very soon.
Matthew: Hi, I’m Matthew Kind. Each week I’ll take you behind the scenes to interview the insiders that are shaping the rapidly evolving legal marijuana industry. Learn more at www.cannainsider.com. That’s www.cannainsider.com. What are the five disruptive trends that will shape the cannabis industry in the next five years? Find out with your free report at www.canninsider.com/trends. That’s www.canninsider.com/trends. Now here’s your program. Leslie Bokskor of Electrum Partners is perhaps one of the most recognized cannabis investors. And as the founding chairman of the Nevada Cannabis Industry Association is one of the state’s most outspoken advocates. I am pleased to welcome Leslie to CannaInsider today. Welcome Leslie.
Leslie: It’s a pleasure to be here. Thank you so much for having me on the show Matt.
Matthew: So listeners get a sense of geography, can you tell us where you are in the world?
Leslie: I’m in Las Vegas, Nevada.
Matthew: Okay, and can you tell us a little bit about your background before getting into the cannabis industry?
Leslie: Sure I’m an investment banker, and I’m working corporate finance by trade and have for the last 25 years. I was one of the first investment bankers to specialize in the internet and media back in the mid to late 90s when it wasn’t even that popular. At the time you may recall, Paul Cornman wrote an article in Red Herring where he said the internet would never amount to much. There wasn’t much money to be made on it. I’ve spent my time, I’m looking for disruptive business models and trends that would fundamentally change the way we do business, live on a massive scale, and that’s sort of what brought me to the cannabis industry.
Matthew: So we’re not too early in the cannabis thing. You think now is the time, it’s coming out on the main stage.
Leslie: Not too early. A friend of mine who is a very noteworthy invested said, “Leslie, we’re not at the ground floor. We’re still in the basement. We’re at the beginning of the beginning.”
Matthew: Oh good. That’s the right place to be.
Leslie: Yes it is. It’s an incredible time. This is an unique moment in history that will never be repeated again. It’s something that a friend of mine who is another investment banker, owns his own brokerage firm, said this is the type of opportunity that you could wait many lifetimes to see repeated.
Matthew: Great. I agree by the way. Now let’s talk a little bit about your investing. What type of cannabis investments are you interested in?
Leslie: Well great question. We are interested in investments that range over a fairly broad spectrum. I like to look at the industry as six separate segments and we’re interested in every one of them. We are interested in businesses that are in the recreational cannabis industry, and that would be cultivation, processing, retail. We are interested in businesses that are in the medical marijuana industry which is actually a very new industry. We are interested in business that will be approaching the nutriceutical and supplement market which is going to be gigantic. We are interested in businesses that are in the pharmaceutical and life science market with the hundreds of cannabinoids in the cannabis plant as well as terpenes and other compounds that are unique to it. There will likely be many, many, many pharmaceutical products being researched and developed over the coming decades based upon the cannabis plant. We are interested a great deal in the industrial hemp market. Hemp is a massive product and a massive industry in and of itself. We don’t even know the sizes. There aren’t even any whitepapers currently that document what the ultimate size of the industrial hemp market will be. It’s going to be massive.
We are interested in the ancillary markets which can be broken up into B2B ancillary products; cultivation equipment, real estate base, software and services, things like that as well as the B2C ancillary markets. So I would say that our interests as investors spans all of those industries and then we have another overlay on looking at investing which is based upon the markets that are developing as each state in the United States and Canada and other countries, but primarily the US and Canada right now start to open up states with different regulatory frameworks and new markets open up. We also look at those as each state is a separate market.
Matthew: Okay. So you’re putting together a fund right now, and you don’t shy away from investments that touch the plant. Can you just talk a little bit about why some investors shy away from that and why you aren’t?
Leslie: Sure. Other investors shy away from it because of the friction between the federal illegally and the state legality. The conflicts between the existing legal environments creates something that most people feel is a risk they’re not willing to add to the other risks that are part of investing normally. We have looked to the guidance given by FinCEN, the Financial Crimes Enforcement Network that works with OFAC and deals with anti-money laundering and other issues. We’ve looked at the guidance given by the Department of Justice, and what we’ve said is if there’s existing guidance, which there is, that tells banks that they can do business with legal cannabis businesses in states with regulatory frameworks where the businesses are operating in line with the regulatory framework, then the bank can take the deposits of those legal cannabis businesses. We look at that guidance as providing a set of parameters that if we exceed that type of criteria, it is good enough for us to invest in. So the difference between us is we’re saying if it’s good enough for the federal government to say a bank can do business with that cannabis company, then it’s good enough for us to invest in.
Matthew: Now are you accepting new investors into your fund now?
Leslie: Yes we actually have many investors who have come to us and that are contemplating coming into the fund. We have not officially started accepting funds yet. We expect to be doing that within days, a week, two weeks. It has been an arduous process to make sure every T is crossed and I dotted so that we can present our investors with the best possible framework for executing our strategies. And so we are about to accept capital in the immediate future.
Matthew: And your investments will be some equity, some loans, both, what will that look like, that mix?
Leslie: It will probably be a across a very broad array, and will be a mixture of both many times. Every individual investment will be looked at differently. I feel I anticipate more often than not we will be making equity investments.
Matthew: Now I heard you give a talk on a panel about due diligence, and that’s a huge topic and for some of us who never seen a diligence list, they really may not understand how much is involved. But can you just give us a quick summary from maybe even an entrepreneur’s point of view, an investor’s point of view why it’s so important to have a diligence list and how to make sure it’s successful for both parties?
Leslie: Absolutely. Due diligence is one of the most important exercises and practices in business especially when you’re contemplating investing or bringing in investment. From the investor’s side due diligence is the system that you set up for creating a check list that allows you to go through an investment and make sure it fits your criteria. Have you checked the background of the operators and when you’ve checked what have you found? Have they had previous successes? Have they had previous liquidity events? Have they had a track record of success? Are there any outstanding issues that you should be aware of with any of the major operators? Has the business had any issues? Is there anything associated with that you should be aware of?
From the entrepreneur’s prospective the more substantial your due diligence package, the better prepared it is, the better evaluation you will be able to defend in your business in terms of attracting investment and bringing it in. If you have an incomplete due diligence package, what will happen is in the process of negotiating with your investors, they will look at your lack of due diligence. They will look at your lack of information, and they will use that as a mechanism to attack your evaluation and bring it down. Saying, wow, you haven’t prepared your outstanding agreements. We don’t understand what the potential liabilities are. We don’t have a complete record of all of your assets, and we don’t have a complete record of all of the debts of people that owe you money and you have not perfected the debts to make sure that they’re absolutely executable and that the debtors will be able to perform according to your debt because you haven’t properly structured it and things like that. If you haven’t done that when an investor is coming in to invest in you, they will look at those things and they will attack that as reasons to lower your evaluation. So what happens is your due diligence file, your due diligence practices can directly affect the evaluation and your cost of capital.
Matthew: Great points. For any new or prospective entrepreneurs out there listening, what are the big problems in the cannabis industry that need to be solved?
Leslie: The biggest problem in the cannabis industry in my opinion has to do with a lack of substantives, self-regulatory organizations. When the alcohol industry transitioned from prohibition to a legal industry in 1933 within one year they had self-regulatory organizations set up to establish standards around packaging, potency, product integrity, marketing and advertising. And since that time the alcohol industry has been incredibly successful at using the self-regulatory organizations to be able to monitor the alcohol industry so that the federal and state governments do not have to come in and regulate them. For example right now there was a recent poll that said 73 percent of children under 18 that don’t drink say the reason they don’t drink is because of communication from their parents about alcohol. That program, getting the parents to talk to the kids about alcohol, was entirely put into place by the alcohol industry through its various self-regulatory organizations. Those organizations created the material, created the context and created programs to help parents understand how to communicate with their kids about alcohol, and gave them talking points, created programs that would teach them how to have those conversations. The result is it’s reduced youth alcohol consumption dramatically.
In an industry like cannabis where many of the cannabis manufacturers market to our own inner children, the problem is that those products are thereby being marketed to children as well. They can’t differentiate that candy bar, that brownie, that cookie, that lemon drop from being something that should be for them. And we need self-regulatory organizations without a doubt to establish standards that will be promulgated throughout the industry so that we will not be having issues about products being created that will have an appeal to people under 18. We need to have programs that instruct parents how to communicate with their children about cannabis, both recreational and medical marijuana. We need to have programs that educate parents and other types and anybody who has cannabis in their home, lock it up. They should be locking up their prescription medications as well. Every 18 minutes in the United States somebody dies from prescription medication. And so whether there’s prescription medication or cannabis we need to have lockable medicine cabinets where it’s kept. We need to have edibles kept in lockable boxes in the refrigerators where it’s kept. These things need to be segregated and kept separately, and the people who can make that happen are going to be self-regulatory organizations. The single biggest problem, in my opinion, in the industry is that we are still setting up the self-regulatory organizations that will be establishing the standards and monitoring the practices of the participants in the industry to make sure that we’re avoiding the issues I just described.
Matthew: You mentioned the packaging and the childproofing education. One thing that jumped out at me while you were talking is that if there’s an entrepreneur out there that can still communicate a strong brand while childproofing, that’s a homerun. Where it doesn’t attract kids, but it’s still very esthetically attractive, but can prevent kids from getting in there. That sounds like that would be something interesting.
Leslie: Absolutely. And I couldn’t agree with you more, and we’re going to see that happen. What we’re going to see is self-regulatory organizations are comprised of the industry participants. And so we will see industry participants, the various industry leaders starting to step up and establish those self-regulatory organizations and leading them. So exactly what you’re describing is what’s going to happen.
Matthew: Now switching gears, in Nevada you’re a huge advocate for Nevada, and I want to hear why. But first can you give a brief update of what happened in Nevada in November and why that’s important?
Leslie: We had in Nevada in November a series of events take place. First off we had the granting of the provisional licenses by the Department of Public and Behavioral Health and that was huge. I think something like 260 provisional licenses were granted. We additionally turned in the petitions for our adult use initiative which will be in the ballot box in 2016. As well we had ArcView, the ArcView Investor Network had a conference here, and we had the MMJ Business Daily conference here. We also had a Women Grow event, and we had the NCIA yearly banquet. All of that took place inside of two weeks. It was a real banner month for cannabis in Nevada.
Matthew: Without having recreational use being legal in Nevada, do you really think they can become the leader, take it away from Colorado, Washington, now Oregon?
Leslie: Nothing that we need to take away from anybody. Nevada is likely going to be a leader in the industry, and we are heading towards recreational use within the next couple of years. We should have it, as I said, on the ballot box in 2016. There’s a possibility that it could get approved legislatively in 2015. And so we are already heading there in addition to having too that our regulatory framework, regardless of whether it’s medical or recreational, which is very much based upon the experience the state has had in regulating gambling which was illegal at the time that the state began to regulate it. It has positioned us to be a leader in regulating cannabis as well. And so we are establishing our leadership not based upon our market and it being recreational or not recreational. We’re establishing our leadership based upon creating a regulatory framework that is business friendly and beneficial to the state, the industry and the citizens and users as a whole. And that’s based upon our experience as establishing the gold standard for regulating another taboo subject which was gaming at the time. That is now accepted everywhere, and the gaming regulation in Nevada is looked at as the gold standard worldwide.
Matthew: Now is the permitting process too expensive and too oriented towards big business to the point where it’s boxing out small family operations?
Leslie: So the answer to that is we want to make sure that this is once again a well regulated industry. And we established a merit based system for determining who is going to be able to participate in that. And it doesn’t matter whether it’s big business or small families. It’s not about the size of your business. It’s about your ability to put together a very comprehensive and well thought out plan. There are many big businesses who put together and who spent a tremendous amount of money to get their licenses approved that did not get provisional licenses because they did not score high enough in the merit based system. And there are many small businesses that did score very highly because they assembled the right team, the right program and put together a better application. So the fact of the matter is the merit based system is going to be able to benefit those who put together the best team, the best program and the best product.
Matthew: One thing I do notice about Nevada is that there is regulations there, but they’re probably more laissez faire than the other states that are allowing medical or recreational cannabis. Is there anything else about Nevada that just makes it a homerun for cannabis there?
Leslie: Yes, I would use… I wouldn’t say we’re laissez faire, I would say that we are being reasonable. We’re having an honest conversation amongst reasonable people about the nature of cannabis, it’s use, medical marijuana, which is why we’re the state that allows anybody from any state, any jurisdiction that has medical marijuana recommendation to come into our dispensaries and purchase cannabis. And so that, in my opinion, is a differentiating factor. I think that we are not… what we have established is a very forward thinking prospective on it, and we’re getting away from the old propaganda that was based upon lies and misinformation.
Matthew: What technology or trends do you see disrupting the cannabis business the next one, three, five years? I know it’s changing so quickly, but you have a focus on disruption so I would like to hear your opinion on that.
Leslie: I think that the cannabis industry is going to actually be a hot bed of innovation because of the friction between federal and state law and the patchwork of different regulatory environments on a state to state basis. What you’re going to see is innovation that’s going to have to be adaptable and take into account all of these differences on a state to state basis; the federal laws, the banking issues, etcetera. And so what’s going to happen is the tremendous upward pressure that is coming from all of the interest in getting into this business, all of the opportunity that it’s creating, the profitability that exists in the business, the rapid growth that exists, all of that capital and that economic force is going to be creating opportunities that will result in innovation being developed to take those other issues into account. That innovation will not only be applicable to the cannabis industry, it is going to be applicable to other industries.
For example, there’s a business out there named CannaBuild. Zach Marburger who is now in Denver, he developed a tool that is going to be providing information to end users to avoid the discomfort of going into a dispensary and not knowing what to get, not knowing what the differences are. He’s created a tool that’s going to allow for a user to be able to understand what they need to get before they get there, to have an actual person walk them through that process so they can walk into the dispensary already having decided what they’re going to get and just going in to pick up their purchase. Rather than having the uncomfortable experience of going in and walking in and not knowing what to get and not understanding and feeling overwhelmed. Not all together different than the way people went into video rental stores and didn’t know what they were going to watch for the night, and walked around trying to figure out. Which is why NetFlix became such a massive opportunity and a massive business going from a $10 million valuation into a $28 billion valuation or whatever the number is right now, over a 15 year period. We’re going to see the same type of innovation come out of the cannabis industry that will be applicable to other industries as well.
Matthew: Leslie I love talking with you. You have a ton of energy, enthusiasm and wisdom. In closing how can listeners follow your work and connect with you?
Leslie: They can get in touch with me through www.electrumpartners.com. That’s www.electrumpartners.com. They can also follow me on Twitter @Leslie Bocskor. And we are very likely going to be launching a website sometime soon. We’re contemplating right now the Electrum Report which will be a daily or at least four times a week newsfeed of the most significant articles in the cannabis industry that affect the cannabis industry that we curate and then present four times a week for people to read.
Matthew: Great. Thanks to Leslie Bocskor for being on CannaInsider today. Thanks Leslie.
Leslie: Thank you Matt. Have a great day.
Matthew: If you enjoyed the show today, please consider leaving us a review on iTunes. Every five star review helps us to bring the best guest to you. Learn more at www.cannainsider.com/itunes. What are the five disruptive trends that will shape the cannabis industry in the next five years? Find out with your free report at www.cannainsider.com/trends. That's www.cannainsider.com/trends. Have a suggestion for an awesome guest on www.canninsider.com, email us firstname.lastname@example.org. We would love to hear from you.
Understanding the changing landscape of concentrates with James Slatic, CEO of Med-West. James talks about why not all vape pens are the same and how discreet infused products like their gums, sprays and sublingual tablets are changing the game. Learn more at Med-west.com In this interview we will reveal how the market for discreet cannabis products will look in the years ahead.
Matthew: Hi, I’m Matthew Kind. Each week I’ll take you behind the scenes to interview the insiders that are shaping the rapidly evolving legal marijuana industry. Learn more at www.cannainsider.com. That’s www.cannainsider.com. What are the five disruptive trends that will shape the cannabis industry in the next five years? Find out with your free report at www.cannainsider.com/trends. That’s www.cannainsider.com/trends. Now here’s your program. Cannabis consumers are moving more and more away from flower and choosing concentrates. We’re going to find out why that is and learn about the most exciting innovations on the cannabis concentrate front with our guest today James Slatic, CEO of MedWest. Welcome James.
James: Thank you.
Matthew: James I want to dig into the extract market, but first can you tell me at a high level what MedWest does?
James: Sure, MedWest was one of the first CO2 extraction companies. We started back in 2009, and we provide a wide array of CO2 extracted cannabis medicines and soft gels, sublingual pills, oils and of course the most popular, well-know thing, the vape pen cartridge system.
Matthew: How did you get involved in extraction and concentrates? What’s your background?
James: Well I think like many in cannabis, by accident, you know. I’m a 30 year entrepreneur. I’ve been starting companies since I was 23, and we always try to find the niches. In entrepreneurial business we say in niches there are riches. And I stumbled upon the medical cannabis world back in 2008, and originally started as doing packaging. I started a company called www.popbottles.com, and we supplied, you know, compliant packaging to about 350 dispensaries around California. And just from networking through the industry I started, you know, going to the conferences, the business conferences and you know, met the OrganaLabs people in Colorado and started learning about the CO2 extracted medicines and really saw that as a thing for the future and for, you know, helping people with medical conditions and just kind of went from there and the rest is history, as they say.
Matthew: Now for listeners that are not that familiar with concentrates or maybe just have a slight understanding of what it is, how can you help orient them about what concentrates actually are and why the market is turning or pivoting so quickly to concentrates and it’s taking more market share from the flower?
James: Well that’s a very deep question. I think the simple explanation is concentrates are basically taking the flower and extracting down the essential elements, the active ingredients. A number of ways to do that, you know, we use CO2 because of the laws here in California against hydrocarbon extraction, but many other states use solvents such as hydrocarbon extraction like butane. And once you remove the active ingredients out of the flower then you can mold it into any number of delivery systems. And so, you know, everything from the famous, you know, pot brownie that everybody knew or heard of before, you know, medical cannabis, and then everything into sort of high tech stuff. I mean we have soft gel capsules with all kinds of varying amounts of CBD and so forth. And so concentrates are now just getting more scientific, and I think the consumers are learning that it provides a doseability or repeatability and you know, lack of stigma. You know, if you light up a joint or a pipe somewhere, everybody within a city block can smell it, versus a concentrate which, you know, looks medical, acts medical and both the people that use it in adult use consumption fashion as well as for medical conditions, it’s very doseable and repeatable.
Matthew: Now you talked a little bit about the categories your concentrates are in, but not everybody is familiar with the sublingual or sprays. Can you talk a little bit about what those are?
James: Sure. It’s just taking the essential ingredients and it’s (5.02 unclear) that you put it in. The sublingual is basically a pharmaceutical sugar base, and so sublingual just meaning that it’s designed to, you know, melt in your mouth. The best way is under your tongue, and it’s what’s called an oral mucosal where it goes in through the mucous membranes of the mouth, and it’s a great delivery method especially for my pain patients because it doesn’t matter what you had to eat or drink or when. It’s going to take effect the same way every time and last the same amount of time. And very similar to a spray, you know, these cannabis sprays that are coming on the market too, they’re also absorbed through the mucous membranes of the mouth. So it takes effect very very quickly, you know, less than 10 seconds and you know, usually very doseable.
Matthew: So you’re saying that it’s more consistent with the concentrates. You can dial in what you want to feel or a patient, what symptoms they want to treat a little easier than the flower?
James: Well definitely. You know, flower is going to, you know, it’s still always going to have a place in the market, but it tends to, as we all know that consume cannabis, you tend to get as high as you’re going to get right away. And then from that point on, you know, five minutes, ten minutes, twenty minutes, you know, you’re going to have that gradual decrease in the effect. So you’re going to need to redose or whatever. Plus when you burn cannabis you tend to get the supporting cannabinoids tend to become fugitive on those temperatures, meaning they escape and are not inhaled into the vapor stream. So that’s why people tend to get, you know, really high and maybe get some of the paranoid effect from these high dosages of THC that are in the highly bred strains now we see, you know, 24-25 percent THC. You tend to get a big hit of that when you burn the cannabis and all the other supporting cannabinoids have a place in the effect and those seem to get across the blood brain barrier better when they’re ingested or you used another method other than smoking.
Matthew: Now you mentioned the other cannabinoids. Let’s talk about CBD for a second, and you have a CBD gum. Can you just describe at a high level what CBD does for patients and a little bit about your gum?
James: Yeah, the Cannabidiol gum is, you know made from a 99 percent, pure 99 plus percent pure CBD extract that we have derived from hemp. As far as I know the only one on the market. We have an exclusive thing to import that. The gum, you know, it’s a great delivery method because it puts it into your system and it’s really being effective for a lot of my diabetic patients with a blood sugar modulation effect. So you know, not being a scientist, you know, to go into all the, you know, medical conditions and what we’re seeing in the CBD research, I’m going to advise all the listeners to just, you know, Google it, CBD and cancer and post traumatic stress. Now we’re seeing some great indications with Alzheimer’s. But, you know, what we try to do with our CBD pills and we have a spray and now the CBD gum that you mentioned was just provide an inexpensive method to get CBD into your bloodstream.
It seems that, you know, my patients are just getting effect from… a good effect from having a modulated amount of CBD in their bloodstream all the time. So, you know, with three or four pieces of gum a day, 25mg a piece, and you can get 100mg in your bloodstream at different times during the day, and without the market and clinical research needed because of the, you know, government interference. It’s hard for me to point to multiple studies. I’d say most of our things are coming from our, you know, hundreds and thousands of patients just giving us their, you know, their personal anecdotal evidence.
Matthew: Right and I know there’s a lot of restrictions on what we can talk about because of the FDA and so forth, but CBD seems like it lends itself to treating certain symptoms more than others. I’ve heard everything from anxiety to autoimmune disorders. Is that kind of the universe of what you’re hearing as well?
James: Yeah it is. You know I’m very excited with this calming effect of CBD. Certainly, you know, it’s not, you know, putting people out or anything, but we are getting a lot of reports and I can give my personal attribute that, you know, a couple pieces of gum and you know, maybe it’s placebo effect, but I definitely do feel that it has a calming effect on the body. You know, as it effects neurotransmitters, it probably makes sense that it does that. So you know, at my age and with my family history I think I’m most excited with the, you know, research news that came out last week about the efficacy in fighting amyloid plaque, you know, which is a lot of the cause of Alzheimer’s.
Matthew: Yes, great point. You offer a cannabis oil syringe. How are patients using the syringe?
James: Multiple ways. Every way from just putting a dab on their finger and rubbing it on their gums to, you know, putting it in teas. And I have a number of cancer patients that, you know, put the cannabis oil because it has, you know, all the supporting cannabinoids and they put it in their, you know, their herbal tea at night or in the morning and just mix it in. And then of course your adult use people, you know, use it, you know, with their just smoking flower, as a bowl topper in the dabbing apparatus.
Matthew: Now are your products only available in California or in other states where medical marijuana is legal?
James: Well our, you know, because of the state laws, everyone knows the companies is you know, domiciled and owned directly in that state, produced in that state, but you know, these same medicines are produced in Washington and Colorado and Arizona and in Michigan.
Matthew: And when I walk into a dispensary I know you’ve got a bunch of different lines of products. What should we look for?
James: The name brand is our flagship and that is where, you know, the medical chocolate and the vape pen cartridges and the CBD/THC sprays and gum are all under the Bang label. So that is the best way, and I think more things are going to just migrate and that will just be our corporate brand. You know we may have one or two, you know, medical CBD pills or so forth that come out under one of the other labels, but most everything will be under the Bang family.
Matthew: Okay so I’m in a dispensary and I wanted to get a cartridge for my vape pen, what is the… let’s say, how much does it cost to get a refill on a cartridge for a vape pen? I’m just trying to give the audience an idea of the cost. I know it varies.
James: Well there’s two, you know, there’s two sizes; the half gram and the full gram. So they’re usually at retail for $30 for the half and $50 for the full.
Matthew: Okay, and the concentrate, extractions and concentrates are moving so fast. It’s really hard to keep up with them. Where do you see this going in the next 3 to 5 years? I mean it’s just unbelievable, the sublinguals and the syringes and everything, the gum. I mean it’s really… this has come about much faster than I even anticipated. Where do you see it going?
James: Well my prognostication skills aren’t that great. I would have bought, you know, Microsoft back in 1984 if I could have seen the future, but I think you’ll see more of a, you know, a trend like you’re seeing now. From the investor’s side, you know, places like ArcView that have shown us how many people want to invest in this space. There are getting to be some very sophisticated, well-funded and great researchers, scientists that are examining coming into the space at various speeds. So I think sort of like, you know, like the computer world. I think you’re just going to see an acceleration of the curve that’s started already, and there’s going to be more and more science behind more precision in dosing, more precision in blending the cannabinoids to get certain desired effects. We’re going to have more details on how CBD, CBN, CBG, THC and how these so called entourage effects work together and help certain conditions and everything from, you know, your mood on down. So I think that, you know, it’s just going to be more and better and, you know, like when the internet started and then holy crap who envisioned, you know, Facebook and everything else that’s come to pass. And I see the same thing because, you know, cannabis market is growing 67 percent a year, and upon adult use coming in California and Nevada, Maine and some other states in the next presidential election in 2016, you know, I just think that the curve is, you know, very much at the infancy.
Matthew: And as we close how can listeners learn more about MedWest and the Bang chocolate and the vape pen and all the different products you offer?
James: I think the best place to start is www.medwest.com, and you’ll see all that in there. We have a good variety of information on there for patients, dispensary owners and so forth, and that’s always a good place to start.
Matthew: Well James thanks so much for coming on CannaInsider today. We really appreciate it. If you enjoyed the show today, please consider leaving us a review on iTunes. Every five star review helps us to bring the best guests to you. Learn more at www.cannainsider.com/itunes. What are the five disruptive trends that will shape the cannabis industry in the next five years? Find out with your free report at www.cannainsider.com/trends. That's www.cannainsider.com/trends. Have a suggestion for an awesome guest on www.cannainsider.com, email us email@example.com. We would love to hear from you.
Alan Brochstein, an expert on cannabis stocks and Jay Czarkowski a dispensary owner turned consultant highlight all the pivotal events that took place in 2014 for the cannabis industry.
– The states that legalized in November
– The wild roller coaster year for cannabis stocks
– The provisions in the omnibus spending bill that prevent the DOJ and DEA from going after cannabis businesses that are following state laws
– How tribal lands are opening up to cannabis
– Nevada, the next state to have a huge impact on the cannabis industry
– The next big brand in cannabis
– Clinical Trials for cannabis as a medication
– Colorado: what worked, what didn’t from a regulatory and business point of view
– Hemp, its time has come, get ready
– Marijuana Business Daily Conference in Las Vegas
– How public opinion is changing even in conservative states
– What 2015 and 2016 look like for the cannabis industry
Matthew: Hi, I’m Matthew Kind. Each week I’ll take you behind the scenes to interview the insiders that are shaping the rapidly evolving legal marijuana industry. Learn more at www.cannainsider.com. That’s www.cannainsider.com. What are the five disruptive trends that will shape the cannabis industry in the next five years? Find out with your free report at www.cannainsider.com/trends. That’s www.cannainsider.com/trends. Now here’s your program. Today we’re going to have a little bit different of a show. I’ve invited two guests Alan Brochstein and Jay Czarkowski to help us digest and understand all the huge changes that have taken place in the cannabis industry in 2014.
A little background on both Alan and Jay before we get started. Alan is an expert on cannabis stocks and investing and is the founder of 420 Investor and 420 Funders, as well as a frequent writer on Seeking Alpha. Jay Czarlowski is a dispensary owner turned cannabis consultant. Jay is a managing partner at CannaAdvisors where he helps clients with not only obtaining cannabis cultivation and dispensary licenses but also with all aspects, the design, build, grow process that comes after winning a license. Welcome to CannaInsider Alan and Jay.
Male: Thanks for having us today.
Matthew: So much ground to cover, 2014 was a huge huge pivotal year guys. Let’s get started with you Jay. What happened in the November election and how should we be thinking about this?
Jay: Well Matt I’m certainly no political analyst, but I can tell you this, the big votes were of course Alaska, Oregon, Washington D.C. and Florida. The first three of course passed. Florida did not, but the important thing about Florida, got 58 percent of the vote. Fifty-eight percent was more, from what I understand, than the last five governors, winning governors received, and I think the most any president got in Florida since Eisenhower. So, you may want to scratch that because I don’t know if that’s accurate.
Matthew: No, no. Fifty-eight percent is what I heard too, and that is absolutely massive.
Jay: And here’s what’s important. It didn’t pass because of course they needed 60 percent, but the people have spoken. You know the voters are on record and the majority of voters in Florida, they want medical marijuana. So hopefully even though it did not pass by referendum, hopefully the legislators take notice and they make something happen in 2015.
Matthew: Now there is certain oils that are legal in Florida though, correct? Is it CBD oils or do you know exactly?
Jay: Sure the CBD or the… it was a limited bill that was passed legislatively for a very very small number of operations just for oil. That program is not yet off the ground.
Matthew: Okay. Now turning to the stock market, Alan, what a crazy roller coaster year it was. Can you just kind of take us back to January all the way up to now? What are kind of the high points of the year?
Alan: Sure. Well the high point of the year that was easy. That was March 18th, and the way I look at it the stocks went up about 7-fold. And going into the year, exactly a year from now, there was a lot of optimism. The stocks has already started to move in anticipation of Colorado, and a lot of stocks doubled the first day of the year. It was so surreal watching the long lines in Colorado and the national and actually global media jumped onto this. So there was…and I had a pretty good vantage point to see what was going on and there were a lot of people who were just learning about the fact that there are stocks that are tied to the cannabis industry. And so we went about two and a half months of just non-stop, up every day and the biggest part of it, from my prospective, was not so much just that these companies that we began the year with started going up, but they multiplied. There were like… we now have about 250 companies, and we started the year with maybe 30 or something like that. And most of them actually aren’t even tied directly to cannabis. So as the years played out, Matt, the market’s been in decline. It’s been pretty steady, not too many bounces. And the way I measure it we’re actually down slightly year-to-date right now.
Matthew: Now the Omnibus Spending Bill, this kind of dovetails into what you were just talking about, Alan, is that in the Omnibus Spending Bill that President Obama signed, they’re withdrawing funds from the Department of Justice and the DEA to go after states that have some sort of framework or laws on how marijuana should be regulated from a medicinal or recreational point of view. Now that the federal government at least said they’re not going to pursue enforcement of this, do you see larger companies going public in pursuing cannabis profits?
Alan: I don’t know if that’s playing a role, but I think the issue about companies getting more involved is definitely topical. We’ve seen this year several companies get involved in Nevada or Illinois. For instance, and some smaller companies or larger ones in the space and then some smaller ones have actually expressed interest in, or done operations in Washington and Oregon and other states like that, even in California to some degree. So this has been a year of a lot of testing by these public companies to see kind of what they can do without getting in too much trouble. And most of the issues that have come up this year have not been related to marijuana. They’ve been related more to penny stock type issues of that matter. So I think this will probably put more wind in the sails of the companies that do want to cross what’s called the green line. So it is very timely.
Matthew: Jay now you’ve watched Colorado go from a medical marijuana market to a medical and recreational or adult use market. What has that change felt like for you as a former dispensary owner? How has the market changed?
Jay: Well certainly it’s difficult to quantify anything negative that’s come from that change. If anything, adults now have a safe, legal access point for cannabis and cannabis products. You know, there’s some talk in Colorado that teen use has not gone up. In fact some will say that teen use has actually dropped. Crime is certainly down in Colorado. In Denver that’s a well publicized statistic. It’s been great for the industry, and now that we have almost a full year behind us of legal cannabis in Colorado and the world has not ended, I think it’s only going to, you know, set the mark for other states in the country, if not other countries across the world to follow in our footsteps.
Matthew: Now Alan you’re in Texas. Now Texas is coming along, but it’s not Colorado. How have you seen public opinion change in your travels, but in specific in Texas?
Alan: You know it’s funny. I’ve travelled a lot this year. Colorado four times, Vancouver which is really maybe the capital of cannabis in North America. But here in Texas it’s interesting. They just hired… MPP just hired a full time lobbyist, and it’s definitely something that we’re working on. There’s been a lot of research out of the Baker Institute, which is part of Rice University. Very pro-cannabis in terms of there was a Texas Monthly article cover story I believe on PTSD for instance. So I see things changing here. There was a marijuana investment conference in September. A ton of interest really from across the state with that. We are on track right now to move towards, in 2017, medical marijuana in Texas. So I think it’s tough. I think I can see how we’re similar to Florida. Whereas Jay pointed out and you discussed the 58 percent approve it, and that’s medical not legal cannabis. But I’ve seen over the last couple of years a big move towards that direction, an open-mindedness towards medical. We’re probably, even in Texas the majority do support it, but there’s a very vocal minority.
Matthew: Now Jay there was a big change in how the federal government looks at cannabis growth in tribal lands all across the country. And you tell us what happened, how the federal government stepped away and what the opportunity is going to be?
Jay: Sure that’s a very very new development that I don’t even think has really fully presented itself yet in terms of details. All we know is that the federal government made an announcement that they would not interfere with tribal nations if they wanted to develop, you know, cultivate and sell. Now I’ll make a couple of examples. CannaAdvisors has begun to look into this only because we have a close relationship with a gal who has done a lot of grant writing for a number of Indian reservations in the west. So she has very very close relationships with a lot of these tribes. What would be a homerun, I will use Colorado as an example is if it would be possible to develop a relationship with an Indian reservation in Colorado where you could not only cultivate it and sell it on the tribal lands, but cultivate it and then distribute out to, you know, any number of dispensaries in Colorado. I think that would present a large number of regulatory issues, you know, potentially at the federal, state and local level. But it’s a conversation worth pursuing. Where it will go, we’ll have to cover that at the yearend review in 12 months I guess, but it’s a very exciting prospect for sure.
Matthew: Go ahead Alan.
Alan: I’ve done some research on that. I’m actually going to take the under in terms of the potential there right now. I think it could play a role in some states, you know, like Jay just mentioned in Colorado where it’s already legal. But the fact is from what I’ve determined the Indian tribes have to follow federal law and state law. And the federal law right now it’s not legal. That was just a Department of Justice interpretation or administrative letter. And as we know that Department of Justice is living on borrowed time right now because we’ll have a new president no matter what in a few years. So to go against state law is going to be a big challenge. I think it was one of these stories that just popped up out of the blue, and it sounds very promising, but I think there’s a lot more exciting things going on in that story.
Matthew: So just to help me understand what the tribal land opportunity and the potential problem is is that potentially the tribal lands might not have as much work to do satisfying certain regulatory requirements because they’re in a sense they’re island within a state and they may be able to do things a little bit easier or on a larger scale or maybe perhaps with a little less oversight. Is that what you’re thinking, Jay and Alan, that that’s what some people are saying the opportunity is?
Jay: Well I think all those things are possible. Let me give you an example. I’ll just use Colorado as an example because I live here and this is where we started our business five years ago. It certainly might be possible for a Colorado Indian reservation to begin to cultivate vast amounts of cannabis flower, but you know how is our state regulatory agency, the MED, how are they going to feel if, you know, the dispensaries begin to purchase from the Indian reservation. I don’t think any dispensary owner would put their license in jeopardy if the state of Colorado did not approve. Then there’s of course all the testing requirement, inventory control and tracking requirements. I think it will be very messy, but again I think it’s an idea worth pursuing and developing and you know seeing where it goes.
Alan: I’ve been tracking this whole concept for a while, but my thinking was it would play out in Canada where they have the federal system and there’s already, I think they call them aboriginals, they’re not Native Americans, kind of a weird term. But I think there’s a bigger likelihood that some of the tribes up in Canada are able to secure a license with Health Canada and for something really big to happen in the United States.
Matthew: Now Alan turning to Nevada, I know you follow a few companies there that are doing big things. Can you tell us what happened as far as Las Vegas granting licenses and who you think will benefit the most from that going forward?
Alan: Sure I know Jay probably can weigh in here too. He’s more expert about this than I am given he’s consulting. But from my prospective, so I’ve been watching this. I have to say, this has been quite remarkable, the amount of transparency from the local level. I’ve watched several county and city hearings that have been… they’re recorded but there are also live web cast on the internet. Very transparent process and as I mentioned earlier we’ve seen some public companies get involved in this process. And the state really tried to avoid some of the problems that have been dogging Massachusetts which still isn’t up and running yet despite the fact that it should have been more than a year ago, if not even longer. So the whole process has run into some problems. You know, I’m not going to point fingers but I will say this. The patients are going to lose.
So there will be some delays in Nevada, and there’s a lot of uncertainty right now about the full number of licenses, but it’s going to move forward. This is exciting to public company investors because there are a couple, actually there’s more than a couple because there’s some lab plays as well. There’s a handful of companies that are publically trading that are involved in this process. Nevada has reciprocity, meaning that anybody that holds a card in another state that comes to Las Vegas on vacation will be able to access these dispensaries. And so it’s going to be a much larger market than you would think based upon just the local population. On top of that, it’s pretty evident that if not in 2015, certainly in 2016 Nevada will be legal. So right now Colorado is the king of cannabis, and it probably will remain so, but I bet you Nevada can give it a run for the money.
Matthew: Jay how about you? What do you think about Nevada?
Jay: Yeah, you know, Nevada is clearly going to be the next great state in the cannabis industry for a lot of the reasons that Alan just mentioned. The reciprocity with other medical states is going to be big, certainly with California being right next door with their one million or so patients. But what’s also important to understand that I don’t think may people do understand is the folks in Nevada over the last few months put forth a petition drive to get legalization on the ballot for 2016. They have to do it that far in advance. And they got the votes that they needed. So if something does not happen legislatively in Nevada in 2015 in terms of full on legalization, it will be on the ballot in 2016. Now I can tell you this. The republicans who currently control things in Nevada, they are very interested in taking care of this issue before the 2016 election for obvious reasons. So don’t be surprised if you see Nevada legislatively pass recreational legalization in 2015.
Matthew: Ah they want to get credit for it is what you’re saying.
Jay: Well they want to get it done before the issue brings out a larger number of democratic voters in 2016, younger voters potentially.
Matthew: Now staying on Nevada for a second, Jay, how many licenses were granted exactly, and do you think that… how do you think the number of licenses that were granted will affect the supply of cannabis that comes onto the market initially and then down the road? Because it was kind of a lot wasn’t it? Is it in your mind?
Jay: Sure if you break it down between dispensary and then cultivation and infused products production, the original state law only limited the number of dispensary licenses. That limit by law was a total of 60. For different reasons, some disparity between local approval and state approval, that number was going to end up being between 40 and 50 would be my guess. Probably closer to 50 to start. Now they were very very generous with cultivation licenses and infused product licenses. Of course there were really no limits, and almost everyone, every team who put forth an application received a license. Now clearly there will be a number of those groups that just don’t have the business wherewithal or the capital to execute, but the majority of them will. Will there be an oversupply of cannabis in Nevada? I just have a tough time believing that there will only because, you know, we’ve been at this now in Colorado for years and we have yet to really have an oversupply that really greatly drives the price down. So even with a large number of cultivation licenses, I’ve got to believe that things are going to be okay. The industry will develop, and I don’t think there will be too big of an oversupply.
Matthew: Now switching gears. Alan you’ve probably heard about the Marley Natural announcement from Privateer Holdings in Seattle. Can you tell us a little bit about that and your thinking? Is this the next big brand of cannabis?
Alan: Yeah it’s too early to say. Obviously it’s a great name, and I have a lot of respect for Privateer. I think most people are familiar with Leafly and come on, and this is actually their fourth area of focus. I think the bigger point, Matt, is that we don’t have brands yet. I’ve been watching the Pot Barons of Colorado. It just ended last night, six episodes. And that was one of the big takeaways. Everybody wants to be the next big brand. And it takes a lot, and the laws right now make it very difficult. For instance, listening to Tripp Keber, who obviously wants to be one of those brands. I think he said it takes $5 million per state to set up the license, you know, the production for the licensees that they want to use. So it takes a lot of capital. So we’ll see if Marley ends up being that brand. There are several others that are front runners, but it’s going to be a tough fight I think as long as we have federal illegal, you know, federally illegal makes it very difficult to establish these brands.
Jay: You know I have some strong feelings on that as well. Guys, and again I’m a big fan as well of what… a big fan of Privateer. I think Brandon’s doing a great job. He has over the last couple of years, but you know I’m certainly a fan of Bob Marley. I used to spend time in Jamaica as a kids and certainly smoked plenty of ganja back in those days. But I mean let’s face it, you know, the industry needs some fresh brands. You know you can only go so far promoting, you know, Bob Marley, Cheech and Chong. I think the industry is ripe and the consumers want some new brands. And I think we will see the start of that of some new brands being developed certainly in 2015.
Matthew: Maybe a Martha Stewart brand?
Jay: You never know.
Matthew: Now Jay you have some interesting ideas around greenhouses versus indoor growth. Can you tell us how you think about this and how the general public should start to maybe shift their opinion of growing plants indoors?
Jay: Sure, I don’t even think they’re really interesting ideas. I think it’s just getting back to basics the way horticulture, the way plants are grown in the world. Now, you know, all these indoor grows, these warehouses, you know, our first grow five years ago was certainly in a warehouse and a lot of them still are today because that’s really where the industry came from. Not from warehouses but from people’s basements, spare bedrooms or garages. And you know, growing indoors was where a lot of this had to be grown over the last 75 years because it had to be hidden. It was illegal. In a lot of the warehouses today in Colorado some of the indoor warehouse operations that are touted is the best operations in Colorado are really just, you know, great big basements. There’s a lot of unnecessary technology. There’s a lot of energy used on lighting. Then of course the light creates heat so we have to use more energy to provide cooling. It’s just not sustainable. And there are larger, more efficient greenhouse operations being built today. Some of them are in operation today in Colorado and there’s certainly many greenhouse operations operational in California and probably a couple of other states.
Indoor growing is just not sustainable. And if you think about it objectively, what else do we grow in a warehouse under artificial lighting? I cannot think of a whole lot except for maybe micro grains. You know I will make a bold statement here today on CannaInsider. The majority of these indoor warehouse grows in Colorado, I just don’t think are going to be around in the next two to three years only because they’re just simply not going to be able to compete economically with the more efficient greenhouse operations. You know we stumbled into this as we were growing our consulting business 12 months ago by hooking up with a gentleman who has been in the horticultural industry for 35 years. He had a PhD in horticulture, worked with some pretty big companies, consulted all over the world. And we began to learn from him that really cannabis is just another plant. It’s certainly unique in a lot of ways, but I think we’ll see in 2015 more traditional horticulture coming into this industry.
Alan: I’d add to that Matt or I’d actually ask a question towards Jay. Isn’t the move towards more extracts which are used for either, you know, direct concentrates or for edibles. Isn’t that going to hasten that move even more?
Jay: Well yeah. You know certainly, I think ideally, Alan, for producing oil I think eventually we’ll want to grow cannabis in fields if you could, you know, clean it up for the oil extraction process. But you know, efficient cultivation of cannabis is only going to drive cost down. It will certainly drive the cost of oil down. So yes I think greenhouse growing is absolutely the way to go especially if you’re just going to turn it all into oil and extract.
Matthew: Now looking back on the year in investing, Alan, what are some of the companies that really stood out? Maybe pick an MVP, and then if you could go back in time to January 1st, which company would you have made the most money in if you put $10,000 in?
Alan: Yeah the MVP is easy. I think GW Pharma is a company… I think we can argue maybe about the valuation that in terms I always ask my subscribers, do you trust the company and are they moving forward. And unfortunately for the 250 or so companies I’m tracking, the vast vast majority I’d have to answer at least one of those questions no. But GW Pharma, I think almost everybody would say yes, but it’s expensive. And so for your listeners that don’t know GW Pharma is a UK company, and they really… I would award them MVP this year because while they were talking about childhood epilepsy and their approach to it, they really pushed it this year and it’s almost a miracle what’s going on. And they started a clinical trial with the FDA, and we could be within two years of these… I mean I don’t know if you know anybody with childhood epilepsy, but the treatments are terrible, the symptoms are horrible and we need this to happen. And to have it happen in a way where we can get doctors on board, and that’s the way GW Pharma’s approaching it, you know, through the FDA.
I think this will be one of the greatest stories ever for cannabis quite frankly and it’s playing out right now. After that, it gets a little bit rougher to identify companies that we can feel really, really good about. To answer your question specifically which company could you have invested in at the beginning of the year. I don’t even want to answer that because quite frankly I don’t have the exact answer. There’s a bunch of what I think are not very good companies that had great years. There’s also some companies that I think are okay that didn’t have such good years. So there are many companies that are still up a lot from the beginning of the year Matt.
Matthew: So March 18th though that was the…that’s when it really just kind of all exploded and it’s just kind of been all over the place since then, but has gone down.
Alan: No it hasn’t been all over the place. It’s been death by a thousand cuts I would say. Unfortunately it’s been, you know, it’s the best of times and the worst of times. And at the beginning of the year I was so nervous and cautious and you know, I guess people hear what they want to hear. I wrote a few articles about it, and it wasn’t sustainable and it brought in people. And I know we’re seeing this in the industry as well. When there’s a lot of money to be made quickly that leads to short cuts and the wrong type of activity quite frankly. And so the rest of the year it’s been trying to correct. I mean I don’t think that you can make the case that penny stocks are a great place to be. Unfortunately that’s where our industry is right now because of the banking laws and all sorts of stigma issues. Whatever the reason we have to deal with what we’re dealing with, but unfortunately even though the prices are, you know, essentially unchanged, some are up, some are down from a year ago. It’s not like people can invest in the space and think that they’re investing in blue chip companies. We’re not there yet.
Matthew: Now you mentioned banking, Alan. Jay what do you see happening with banking in 2015?
Jay: Well Matt I have been predicting and hoping for changes in the banking regulations for five years. So I don’t want to predict that it’s going to be fixed in the next year, but clearly things are heading in the right direction. In Colorado we are supposed to have a credit union opening up in 2015 and it’s going to cater to the cannabis industry. I don’t know the details on that, but I am actively looking to find out only for our own in house and our client purposes, but it’s a big problem. It’s shocking. I know of two or three businesses and they don’t even touch the plant. They’re ancillary businesses to the cannabis industry that just had their accounts shut down last month. So it’s still a problem, and gosh I can’t wait for it to be fixed.
Alan: Jay I tried to open a bank account. I don’t touch cannabis. I don’t, I mean I’m saying my business doesn’t touch cannabis. I couldn’t open a bank account because I used the word cannabis. I mean it’s ridiculous.
Alan: Hey Matt I was in.. well we were all in Nevada last month, and I thought one of the most interesting presentations was by the CEO of First Nevada. Is that the name? No, I’m blanking out on the name, but Security, First Security, sorry I don’t remember the name. But there is a bank in Nevada that obviously there’s no business open yet there, but when it’s open there will be banking in Nevada. And this is really exciting. One of the takeaways I got from his presentation, he’s kind of a trailblazer. So he’s opening all of these accounts, but nobody’s doing business yet. And so if they don’t get shut down, then it’s a go. And they are a state licensed bank. They’re not a federally chartered bank. But he said in his presentation at the conference that for the banking system to really get fixed, we need to see cannabis rescheduled. So that’s something to look out for.
Matthew: Now Alan there’s some clinical trials going on in terms of marijuana as an actual medicine that we would kind of think of as a medicine that a doctor prescribes. Can you tell us a little bit about that?
Alan: Yeah, you know, I think this is one of the most essential things for the industry. I’m actually working on something right now for year end. We need medical marijuana to be more medical. And this has to do with not just like you walk into a dispensary and it doesn’t seem like it’s medical, but it’s also, it goes a lot deeper than that. It goes to standardization of product. It goes to delivery mechanisms. No other medicine in the world is smoked. And maybe this is the exception. But we need to see clinical trials. We need to see proof. Even though the anecdotal evidence is clear, we need to see this done in a way where doctors can feel more comfortable about prescribing cannabis to their patients. This will help all the states where we have legal cannabis or medical marijuana right now. It will also help states like mine, Texas, or the others like where we just missed in Florida. When they have that evidence they will be able to move forward.
One of the travesties this year was Dr. Sue Sisley’s work on post traumatic stress disorder. This was a project that was funded and ready to go in the University of Arizona. There was some politics and they fired her. Recently she just received a $2 million grant. This is incredible. It was from the state of Colorado which is really nice. The recycling, reinvesting into the industry. The problem is and I just communicated with her this weekend, she can’t get the cannabis. In the United States there’s only one place to get marijuana for your studies and it’s from NIDA, the National Institute on Drug Abuse which is kind of ironic. They’re not about promoting marijuana research. And they have been stymied by NIDA so far, even though NIDA approved it in June after the March application. So hopefully that goes through. I think PTSD, I mentioned childhood epilepsy earlier. These are things that I can’t imagine anybody not wanting to help these patients. The veterans are a primary audience there. These people, whether it’s pain or trauma, psychological stress that they come back from after fighting on behalf of us, we know that cannabis can help them. We need to study it. I’m kind of excited about this. I think we’ll see more of this next year.
Matthew: Jay switching gears to hemp. You know hemp doesn’t get as much attention or the spotlight like cannabis does, but this Omnibus Spending Bill that went through looks like there’ll be even less enforcement on hemp. But in particular in Colorado how do you see that helping the state? How do you think hemp is going come into play in Colorado?
Jay: Well, you know, I know as of two years ago growing hemp became legal in Colorado. I am not a hemp expert. I’m not very involved in hemp production right now. But I can tell you this much, Matt, we’re the only industrialized nation in the world that does not grow its own hemp. And that’s quite shocking especially with all of the uses that we could, as a nation, with our ingenuity what we can do with the hemp plant. And that’s beginning to happen now. What do I see in it for Colorado? I see Colorado becoming the national leader in not only the production of hemp, at least for the time being. I think there’s probably better areas in the nation to cultivate hemp, but right now if we’re it and there’s other states that are following on our heels as we speak. Once we begin to process the hemp and begin to make products from it, you know, we’ll probably have a short window where we could establish ourselves as a leader.
Matthew: Now that plays right into the next question. Where do you see Colorado? What did they do right in 2014, and what did they get wrong overall?
Jay: Sure, well, I think the most important thing that we did right in Colorado in 2014 was January 1st of last year? And I’ll tell you this, the Czarkowski family was up early that morning, and we all travelled down to Denver. It was about [6:30] in the morning New Year’s Day, and we went to the 3D dispensary just because we wanted to be there to witness the first recreational sale and we did. And what was very telling and very important about that first recreational sale it was to a US Army veteran who suffered from PTSD. And this young man was not able to purchase cannabis legally because PTSD was not one of the accepted medical conditions in Colorado to become a medical marijuana patient. So he was there day one to purchase cannabis to treat his PTSD. The biggest thing Colorado did right was to make that big leap and become the first place in the world where people could by cannabis legally. That was huge.
Matthew: Wow there’s probably a lot of excitement there that morning I would imagine.
Jay: It was very exciting. I had no idea until we pulled up and there were probably no less than a dozen satellite news trucks parked out front. And there was so much national and international press that this young Army veteran, he had to actually make two purchases because they could only fit about half of the press in the dispensary at a time. So he kind of went through two purchases so that all of the press could have a chance to photograph him and everything else. Now what has Colorado done wrong and, you know, where do we have to go? I mean we’re pioneers in this. So do we… does Colorado have it all figured out, of course not. We have a long way to go, but Colorado has taken a lot of steps to improve things this year. I think one of the big improvements has been on the labeling of edibles and more accurate dosing, more accurate labeling. That’s a big step in the right direction. There’s still a lot of work to be done.
Alan: From the outside it seems like the government and the industry are working very well together Jay.
Jay: For sure, you know, I think the industry and the state regulatory board are working well together. I think there’s a number of local municipalities that are very supportive of the industry, and there’s also a number of local municipalities that are quite hostile to the industry even now after five years of medical. But the state as a whole, you know, they are, you know, enacting the will of the voters.
Matthew: Yeah. Now looking ahead to 2015 and I also want to lump in 2016 because that’s just such a huge year. Alan why don’t you tell us what you see coming down the pipe for 2015-16.
Alan: Well we didn’t really touch on Canada too much.
Matthew: Yeah let’s touch on Canada.
Alan: Well so that would be part of my response. I think when we talk about things like this usually people are focused on which state is next. And I think we haven’t talked about Canada and I’ll do that in just a second, but also California. And it’s interesting because Jay and I are both very bullish on Nevada but that could change in a heartbeat if they got things right in California. That would be one of the most amazing things, and it’s possible that they could get some competition. You know Jay laid out a case where maybe Nevada goes legal in 2015. That may push California in 2016. So I think we are down the road already and there’s no turning back. And so we’ll see some of these states play out and obviously California would be a big one.
I think Canada is really interesting and most Americans aren’t really paying attention to it. But they have a federally legal marijuana program, medical marijuana program up there, and you know there’s large scale production facilities that are being constructed right now. It’s not a perfect system at all and it’s been off to a slow start, really need to go there, but certainly a little bit of a disappointment in 2014. But I think that’s going to really come on strong and they may move towards legalization in Canada in 2016. They have, there’s some federal election there and that’s already an issue that’s being discussed. So I think that could definitely be something to keep an eye on. I’m not looking for any sort of progress on federal legalization, but I am hoping that in 2015-16 we see potentially rescheduling or at least a discussion about that. There were hints this year of conversations between the FDA and the DEA, and I think that would be huge if we could see that next year. I think that would help unlock the banking problems as well.
Matthew: How about you Jay?
Jay: Well in 2016 we’ll certainly see a number of states legalize cannabis. And like Alan I also love the program in Canada, the first federal program. In terms of states that I think are going to go in 2016, I think a lot of people are betting on Arizona, Nevada and a number of New England states as well as Canada. One thing that I like about New England is that it’s a small area. So if one state in New England, I’m going to use Rhode Island as an example, Rhode Island is looking pretty good for possible legalization in 2015. Well what is that going to mean for the medical program in Connecticut which is quite limited right now when people could just travel across the border. You know drive 30 to 45 minutes and purchase cannabis legally. I think as more states begin to go legal it’s going to put a certain amount of pressure on other states to follow suit.
Matthew: Yeah that makes sense. But you know one thing that intrigues me is that some states, Jay, just don’t get it right are just doing it. You know we gave Colorado a good score here overall, but some states are just doing a terrible job and they’re not creating functioning markets. I mean will they really feel that pressure to change as the other states, you know, turn up the heat a little bit or is it just they’re so mired in dysfunction that there’s no hope?
Jay: Well I don’t know if it’s dysfunction, and I hate to use the word ignorance, but let’s just say a lot of people in a lot of places are still learning. You know, whenever we move in to a new state and we begin to compete for licenses, you know, it’s new. It’s new to a lot of people and a lot of times what people don’t understand is scary and we run across that a lot. You know I make the joke out at Massachusetts, certainly in Connecticut when we’re working out there competing for licenses. You know, everywhere we went the local government, local officials, you know, you would think that we were working with plutonium. I say that word all the time, but you know you would think that we’re dealing with plutonium. But as people begin to get comfortable with this, which let’s face it, in a lot of places now people are beginning to get more comfortable with this. And as people become more comfortable with this plant and they realize that not only is it a lot less harmful than alcohol, but there are also tremendous benefits to its use, I think we’re going to see government officials in a lot of states and local municipalities begin to pass laws to grant their citizens access.
Alan: I think that’s really well said. I think it’s scary for a lot of people. And we see a lot of these programs. Jay, I’m sure you’re very critical of them like New York State what they just proposed, very similar to Minnesota. Highly, highly restrictive, not good enough patient access. When we do see a state come on it takes longer than we’d expect. Everybody’s worried about who’s making money instead of helping the patients. I think over time this all gets better.
Jay: Sure. It’s a lot of stepping stones. I’ll use Illinois as an example only because right now in terms of a state and you know, we’re supposed to hear any day now, possibly this week on who won licenses in Illinois. Talk about a restrictive program. To become a patient in Illinois, you have to go through a background check. You have to be fingerprinted. Now you can go to the pharmacy, get a giant bottle of Percocet and drive home with that and a bottle of Jack Daniels, but if you want to get some cannabis, I mean they literally, you know, treat you like a criminal. But you know, keep in mind the reason that is is because when it was time to pass that law in Illinois, and they needed to get the votes that they needed to make it happen, they had to give these concessions. It’s a stepping stone. Do I think the program in Illinois is going to be that restrictive in, you know, three or four years, god I would think absolutely not, and the same with Minnesota and New York.
Matthew: Now Alan and Jay too, you were both at the Marijuana Business Daily conference in Las Vegas this year. Can you just king of paint a picture of what it’s like there for the people that might not have gone, and how it was different from last year, how much it’s grown or changed?
Alan: I’ll take that first. I wasn’t at the one from the year before, but I attended a lot of conferences this year. And it struck me for the first time, at least in my observation, that one of the big problems for this industry has been new entrance versus people who are more entrenched not getting along. And it seemed to me that everybody was getting along and realizing that both those camps bring something to the table. So that was one of my major takeaways. I was able to obviously review the statistics from a year ago when the number of people was, you know, more than 100 percent I believe. So obviously the industry, it was a great sign for the industry that that many people were willing to take the time to participate. But my takeaway was really just maybe more of a hope for better cooperation among the players in the industry.
Jay: You know, it was only 25 months ago that MJ Business Daily held the first true business conference, and that was in Denver and there were maybe a couple hundred people there. That’s when I met some of the first folks that we began to work with in Massachusetts. I think I remember that was the event I met Steve D’Angelo for the first time. It was a small event. The following year which was, you know, 13 months ago in Seattle it was at a horse race track outside of Seattle, and I think there were about 500 to 600 people there, and it was a good event. You know, this year I don’t know what the final was. Was it 3,500 or 3,600, and I think more people that wanted to get in, I think, from what I understand from talking to some of the security folks, 40 to 50 people that attempted to sneak in without a ticket and that were eventually escorted off the property. It was crazy. You know people came from all over the world to the last business conference in Vegas. You know, I don’t mean to shamelessly promote anyone, but I can tell you this, a lot of different businesses are coming out of the woodwork putting on conferences. You know, I feel that the MJ Business Daily was the first, and I feel like they just do such a great job with trying to do what they can to, you know, come up with a good board of speakers without any favoritism, the people that are their friends, to really put forth good content. I know next year their fourth annual conference is going to be back in Las Vegas. And god if I were to make a prediction of attendance, I’m going to say it’s going to jump from 3,500 to 10,000.
Alan: I thought it was in Chicago actually in May.
Jay: They’re doing something different. They’re going to have a mid-year conference this year. So they’re going to conferences now… the big one is still going to be in Las Vegas in November of 2015, but they’re going to have a mid-year conference in Chicago in May.
Alan: Got it. Thanks for clearing that up.
Jay: Yeah and they were originally, when they came out with their marketing for the Chicago conference, they said that they expected about 1,000 people. But I can tell you this, you know, my company is going to be one of the sponsors. And I received an email from them a couple of weeks ago where they tripled the amount of event space. So, yeah, you know, what does that say for attendance, I think they’re probably going to end up with a lot more than 1,000 people in Chicago.
Alan: And kudos to them. They stepped it up. They brought in a professional from the outside who’s been working with them since, I think, since May. And he’s done a really good job. That’s great for the industry.
Jay: Yeah they’re doing a good job.
Matthew: Well in closing, Alan, can you tell us where listeners can learn more about your work at 420 Investor and elsewhere?
Alan: Sure. So www.420investor.com is where I can be found, and I’m pretty known for that. And that’s our community focused on publicly traded stocks. And this year I also opened another community called www.420funders.com. It’s evolving a little bit. The primary focus there, Matt, was to connect… there’s still a huge problem. A lot of people that want to invest in the industry and a lot of private companies that are seeking investment they can’t connect. And so that’s one of the answers that I have to create a way for them to connect. But I’m also taking that concept one step further. Recently I started focusing on some of the people in the market who are investing on behalf of others like Privateer. ArcView doesn’t actually invest on behalf of others, but I’m trying to bring a level of outside review to some of these entities like Poseidon Asset Management as well or Electrum Partners. So I’m going to be hopefully spending some of my time helping people who want to invest in private places, find people that can help them or also invest directly if that’s what they choose. And that’s www.420funders.com.
Matthew: Well that’s helpful because I know there’s a lot of investors that would like to find a way to participate but don’t know where to start. So that’s great. Jay, can you tell us a little bit about what CannAdvisors does and how listeners can connect with you?
Jay: Sure, the easiest way to find us is go to www.thinkcanna.com, like think about it, t-h-i-n-k. And of course when spelling canna, please don’t forget to put two n’s in the middle. I think we can also be reached through www.cannaadvisors.com. But we have been in the industry since 2009. I like to describe us as a group of battle scar veterans from the early days here in Colorado. And we have been competing for and winning competitive licenses, building operations and managing facilities since 2009.
Matthew: Well Alan and Jay, thank you so much for coming on CannaInsider and doing this yearend wrap up. I really appreciate it, and Happy New Year to you both.
Alan: Happy New Year to both of you.
Jay: Matt, thanks for having us, and Matt and Alan Happy New Year.
Matthew: If you enjoyed the show today, please consider leaving us a review on iTunes. Every five star review helps us to bring the best guests to you. Learn more at www.cannainsider.com/itunes. What are the five disruptive trends that will shape the cannabis industry in the next five years? Find out with your free report at www.cannainsider.com/trends. That's www.cannainsider.com/trends. Have a suggestion for an awesome guest on www.cannainsider.com, email us firstname.lastname@example.org. We would love to hear from you.